ImmunoGen, Inc.

  • Market Cap: Mid Cap
  • Industry: Biotechnology
  • ISIN: US45253H1014
USD
31.23
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'23
Jun'23
Mar'23
Dec'22
Sep'22
Jun'22
Mar'22
Net Sales
113.42
83.15
49.87
41.17
15.38
14.16
38.08
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
113.42
83.15
49.87
41.17
15.38
14.16
38.08
Raw Material Cost
2.15
0.91
0.63
0.60
0.42
0.46
0.47
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.59
4.40
0.85
0.97
0.87
1.08
1.25
Selling and Distribution Expenses
37.74
36.36
40.02
41.64
33.20
23.34
16.18
Other Expenses
4.40
4.57
5.08
5.75
5.83
5.03
4.30
Total Expenditure (Excl Depreciation)
87.47
87.34
92.26
100.73
92.80
75.22
60.93
Operating Profit (PBDIT) excl Other Income
26
-4.2
-42.400000000000006
-59.6
-77.4
-61.1
-22.9
Other Income
7.22
5.21
2.23
2.74
0.54
0.11
-0.04
Operating Profit (PBDIT)
33.60
1.45
-39.71
-56.39
-76.46
-60.48
-22.42
Interest
3.59
4.40
0.85
0.97
0.87
1.08
1.25
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
111.27
82.24
49.24
40.56
14.95
13.70
37.60
Depreciation
0.42
0.43
0.45
0.43
0.42
0.46
0.47
Profit Before Tax
29.58
-3.37
-41.01
-57.79
-77.75
-62.02
-24.14
Tax
-1.17
0.88
0.00
1.22
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
30.75
-4.25
-41.01
-59.01
-77.75
-62.02
-24.14
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
30.75
-4.25
-41.01
-59.01
-77.75
-62.02
-24.14
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
30.75
-4.25
-41.01
-59.01
-77.75
-62.02
-24.14
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
561.60
490.84
121.92
155.83
178.01
249.83
306.47
Earnings per share (EPS)
0.11
-0.02
-0.16
-0.23
-0.31
-0.24
-0.1
Diluted Earnings per share
0.11
-0.02
-0.16
-0.23
-0.31
-0.24
-0.1
Operating Profit Margin (Excl OI)
22.88%
-5.04%
-85.01%
-144.68%
-503.6%
-431.1%
-60.01%
Gross Profit Margin
26.45%
-3.54%
-81.35%
-139.34%
-502.97%
-434.71%
-62.17%
PAT Margin
27.11%
-5.11%
-82.24%
-143.34%
-505.72%
-437.94%
-63.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2023 is 636.36% vs 67.39% in Sep 2022

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2023 is 139.46% vs -108.58% in Sep 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2023 is 134.29% vs -127.81% in Sep 2022

stock-summary

Interest

YoY Growth in quarter ended Sep 2023 is 300.00% vs -67.86% in Sep 2022

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2023 has improved from Sep 2022

Compare Quarterly Results Of ImmunoGen, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
113.42
110.56
2.86
2.59%
Other Operating Income
0.00
0.00
0.00
Total Operating income
113.42
110.56
2.86
2.59%
Raw Material Cost
2.15
4.27
-2.12
-49.65%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.59
37.64
-34.05
-90.46%
Selling and Distribution Expenses
37.74
128.54
-90.80
-70.64%
Other Expenses
4.40
7.36
-2.96
-40.22%
Total Expenditure (Excl Depreciation)
87.47
244.04
-156.57
-64.16%
Operating Profit (PBDIT) excl Other Income
25.96
-133.47
159.43
119.45%
Other Income
7.22
-11.24
18.46
164.23%
Operating Profit (PBDIT)
33.60
-143.40
177.00
123.43%
Interest
3.59
37.64
-34.05
-90.46%
Exceptional Items
0.00
0.69
-0.69
-100.00%
Gross Profit (PBDT)
111.27
106.30
4.97
4.68%
Depreciation
0.42
1.32
-0.90
-68.18%
Profit Before Tax
29.58
-181.66
211.24
116.28%
Tax
-1.17
2.10
-3.27
-155.71%
Provisions and contingencies
0.00
0
0.00
Profit After Tax
30.75
-181.90
212.65
116.90%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
30.75
-181.90
212.65
116.90%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
-1.85
1.85
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
30.75
-183.76
214.51
116.73%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
561.60
-1,787.86
2,349.46
131.41%
Earnings per share (EPS)
0.11
-0.95
1.06
111.58%
Diluted Earnings per share
0.11
-0.95
1.06
111.58%
Operating Profit Margin (Excl OI)
22.88%
-120.72%
0.00
143.60%
Gross Profit Margin
26.45%
-163.11%
0.00
189.56%
PAT Margin
27.11%
-164.52%
0.00
191.63%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 11.34 Million
in Sep 2023

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2023 is 36.30% vs 66.73% in Jun 2023

stock-summary

YoY Growth in quarter ended Sep 2023 is 636.36% vs 67.39% in Sep 2022

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.07 Million
in Sep 2023

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2023 is 830.95% vs 89.76% in Jun 2023

stock-summary

YoY Growth in quarter ended Sep 2023 is 139.46% vs -108.58% in Sep 2022

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.64 Million
in Sep 2023

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2023 is 794.74% vs 90.93% in Jun 2023

stock-summary

YoY Growth in quarter ended Sep 2023 is 134.29% vs -127.81% in Sep 2022

Quarterly - Interest
Interest 0.36 Million
in Sep 2023

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2023 is -18.18% vs 388.89% in Jun 2023

stock-summary

YoY Growth in quarter ended Sep 2023 is 300.00% vs -67.86% in Sep 2022

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.88%
in Sep 2023

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2023 has improved from Jun 2023

stock-summary

YoY Growth in quarter ended Sep 2023 has improved from Sep 2022